Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,008 | -6,377 | -230,762 | -167,747 | -122,690 |
| Depreciation Amortization | 26,385 | 12,978 | 62,126 | 89,874 | 30,296 |
| Income taxes - deferred | N/A | N/A | -20 | N/A | N/A |
| Accounts receivable | -5,626 | -7,914 | 12,816 | 15,777 | 10,661 |
| Accounts payable and accrued liabilities | 4,362 | 6,162 | -7,347 | -1,832 | 1,074 |
| Other Working Capital | -6,751 | -5,825 | -7,982 | 11,447 | 6,632 |
| Other Operating Activity | 22,295 | 9,641 | 113,596 | 17,676 | 54,372 |
| Operating Cash Flow | $12,657 | $8,665 | $-57,573 | $-34,805 | $-19,655 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,807 | -4,437 | -13,149 | -11,035 | -7,375 |
| Net Acquisitions | N/A | N/A | -18,990 | -18,990 | -18,990 |
| Other Investing Activity | 0 | 0 | 734 | 734 | 0 |
| Investing Cash Flow | $-4,807 | $-4,437 | $-31,405 | $-29,291 | $-26,365 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150,000 | N/A | N/A | N/A | 0 |
| Debt Repayment | -294,240 | -51,360 | -5,440 | -4,650 | -2,720 |
| Other Financing Activity | -9,966 | -3,866 | -11,059 | -10,033 | -3,714 |
| Financing Cash Flow | $-154,206 | $-55,226 | $-16,499 | $-14,683 | $-6,434 |
| Exchange Rate Effect | 47 | 30 | -32 | -46 | -38 |
| Beginning Cash Position | 216,890 | 216,890 | 322,399 | 322,399 | 322,399 |
| End Cash Position | 70,581 | 165,922 | 216,890 | 243,574 | 269,907 |
| Net Cash Flow | $-146,309 | $-50,968 | $-105,509 | $-78,825 | $-52,492 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,657 | 8,665 | -57,573 | -34,805 | -19,655 |
| Capital Expenditure | -4,807 | -4,437 | -13,149 | -11,035 | -7,375 |
| Free Cash Flow | 7,850 | 4,228 | -70,722 | -45,840 | -27,030 |